Annual report pursuant to Section 13 and 15(d)

Net loss per share (Tables)

v3.20.4
Net loss per share (Tables)
12 Months Ended
Dec. 31, 2020
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the year end periods presented below:
 
   
2020
   
2019
 
Series A and B warrants
   
6,331,674
       
Stock options
   
1,784,198
     
1,037,705
 
Restricted stock awards
   
40,000
     
 
Former Rexahn warrants
   
66,538
       
Former Rexahn options
   
123